Reverse engineering neuron-type-specific and type-orthogonal splicing-regulatory networks using diverse cellular transcriptomes
Cell-type-specific alternative splicing (AS) enables differential gene isoform expression between diverse neuron types with distinct identities and functions. Current studies linking individual RNA-binding proteins (RBPs) to AS in a limited number of neuron types underscore the need for holistic modeling. Here, we use network reverse engineering to derive a map of the neuron-type-specific AS-regulatory landscape of 133 mouse neocortical cell types using pseudobulk transcriptomes derived from single-cell data. We infer the regulons of 350 RBPs and their cell-type-specific activities, among which we validate Elavl2 as a key RBP for medial ganglionic eminence (MGE)-specific splicing in GABAergic interneurons using an in vitro embryonic stem cell (ESC) differentiation system. We also identify a module of exons and candidate regulators specific to long- and short-projection neurons across multiple neuronal classes. This study provides a resource for elucidating splicing-regulatory programs that drive neuronal molecular diversity, including those that do not align with gene-expression-based classifications.
Authors
- Huijuan Feng (ORCID: https://orcid.org/0000-0002-4005-560X)
- Melissa Campbell (ORCID: https://orcid.org/0000-0002-8358-7307)
- Andrea Califano (ORCID: https://orcid.org/0000-0003-4742-3679)
- Edmund Au (ORCID: https://orcid.org/0000-0003-3190-9711)
- Miquel Anglada-Girotto (ORCID: https://orcid.org/0000-0003-1885-8649)
- Daniel F. Moakley (ORCID: https://orcid.org/0000-0002-3279-4189)
- Chaolin Zhang (ORCID: https://orcid.org/0000-0002-8310-7537)
Institutions
- Columbia University (US)
Publication Details
- Journal
- Cell Reports
- Published
- 2025-06-24
- DOI
- https://doi.org/10.1016/j.celrep.2025.115898
- Citations
- 4
- Primary Topic
- RNA Research and Splicing
- Type
- article
- Field-Weighted Citation Impact
- 3.22
Funders
- Centres de Recerca de Catalunya
- Boehringer Ingelheim Fonds
- Generalitat de Catalunya
- Ministerio de Ciencia e Innovación
- National Institutes of Health
- Agencia Estatal de Investigación